EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:17154 - nicotinamide
| Formula | C6H6N2O |
| Net Charge | 0 |
| Average Mass | 122.127 |
| Monoisotopic Mass | 122.04801 |
| SMILES | NC(=O)c1cccnc1 |
| InChI | InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9) |
| InChIKey | DFPAKSUCGFBDDF-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Homo sapiens (ncbitaxon:9606) | |||
| blood (UBERON:0000178) | PubMed (22626821) | ||
| urine (BTO:0001419) | PubMed (2026685) | ||
| breast milk (ENVO:02000031) | PubMed (24027187) | ||
| - | MetaboLights (MTBLS368) | From MetaboLights | |
| - | MetaboLights (MTBLS264) | From MetaboLights | |
| - | MetaboLights (MTBLS267) | From MetaboLights | |
| - | MetaboLights (MTBLS265) | From MetaboLights | |
| - | MetaboLights (MTBLS290) | From MetaboLights | |
| - | MetaboLights (MTBLS214) | From MetaboLights | |
| - | MetaboLights (MTBLS127) | From MetaboLights | |
| - | MetaboLights (MTBLS266) | From MetaboLights | |
| - | MetaboLights (MTBLS263) | From MetaboLights | |
| - | MetaboLights (MTBLS292) | From MetaboLights | |
| Saccharomyces cerevisiae (ncbitaxon:4932) | - | PubMed (24678285) | Source: yeast.sf.net |
| Escherichia coli (ncbitaxon:562) | - | PubMed (21988831) | |
| Mus musculus (ncbitaxon:10090) | - | PubMed (19425150) | Source: BioModels - MODEL1507180067 |
| Roles Classification |
|---|
| Chemical Role: | antioxidant A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides. |
| Biological Roles: | human urinary metabolite Any metabolite (endogenous or exogenous) found in human urine samples. EC 3.5.1.98 (histone deacetylase) inhibitor An EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor that interferes with the function of histone deacetylase (EC 3.5.1.98). Saccharomyces cerevisiae metabolite Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae ). EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor An EC 2.4.2.* (pentosyltransferase) inhibitor that interferes with the action of a NAD+ ADP-ribosyltransferase (EC 2.4.2.30). cofactor An organic molecule or ion (usually a metal ion) that is required by an enzyme for its activity. It may be attached either loosely (coenzyme) or tightly (prosthetic group). mouse metabolite Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). Sir2 inhibitor An EC 3.5.1.98 (histone deacetylase) inhibitor that interferes with the action of Sir2. Escherichia coli metabolite Any bacterial metabolite produced during a metabolic reaction in Escherichia coli. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. water-soluble vitamin (role) Any vitamin that dissolves in water and readily absorbed into tissues for immediate use. Unlike the fat-soluble vitamins, they are not stored in the body and need to be replenished regularly in the diet and will rarely accumulate to toxic levels since they are quickly excreted from the body via urine. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Applications: | anti-inflammatory agent Any compound that has anti-inflammatory effects. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. geroprotector Any compound that supports healthy aging, slows the biological aging process, or extends lifespan. nutraceutical A product in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| nicotinamide (CHEBI:17154) has functional parent nicotinic acid (CHEBI:15940) |
| nicotinamide (CHEBI:17154) has role Escherichia coli metabolite (CHEBI:76971) |
| nicotinamide (CHEBI:17154) has role Saccharomyces cerevisiae metabolite (CHEBI:75772) |
| nicotinamide (CHEBI:17154) has role anti-inflammatory agent (CHEBI:67079) |
| nicotinamide (CHEBI:17154) has role antioxidant (CHEBI:22586) |
| nicotinamide (CHEBI:17154) has role cofactor (CHEBI:23357) |
| nicotinamide (CHEBI:17154) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| nicotinamide (CHEBI:17154) has role EC 3.5.1.98 (histone deacetylase) inhibitor (CHEBI:61115) |
| nicotinamide (CHEBI:17154) has role geroprotector (CHEBI:176497) |
| nicotinamide (CHEBI:17154) has role human urinary metabolite (CHEBI:84087) |
| nicotinamide (CHEBI:17154) has role metabolite (CHEBI:25212) |
| nicotinamide (CHEBI:17154) has role mouse metabolite (CHEBI:75771) |
| nicotinamide (CHEBI:17154) has role neuroprotective agent (CHEBI:63726) |
| nicotinamide (CHEBI:17154) has role Sir2 inhibitor (CHEBI:71181) |
| nicotinamide (CHEBI:17154) is a pyridine alkaloid (CHEBI:26416) |
| nicotinamide (CHEBI:17154) is a pyridinecarboxamide (CHEBI:25529) |
| nicotinamide (CHEBI:17154) is a vitamin B3 (CHEBI:176839) |
| Incoming Relation(s) |
| N-{5-[4-(4-methylpiperazin-1-yl)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}nicotinamide (CHEBI:39634) has functional parent nicotinamide (CHEBI:17154) |
| N-glycosylnicotinamide (CHEBI:25526) has functional parent nicotinamide (CHEBI:17154) |
| N-methylnicotinamide (CHEBI:64399) has functional parent nicotinamide (CHEBI:17154) |
| 1-[(2-chlorophenyl)methyl]-2-oxo-6-(trifluoromethyl)-3-pyridinecarboxamide (CHEBI:114321) has functional parent nicotinamide (CHEBI:17154) |
| 1-[[oxo(3-pyridinyl)methyl]amino]-3-(4-propan-2-ylphenyl)thiourea (CHEBI:120875) has functional parent nicotinamide (CHEBI:17154) |
| 1-methylnicotinamide (CHEBI:16797) has functional parent nicotinamide (CHEBI:17154) |
| 2-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-3-pyridinecarboxamide (CHEBI:91424) has functional parent nicotinamide (CHEBI:17154) |
| 2-(2,4-dimethylanilino)-N-(thiophen-2-ylmethyl)-3-pyridinecarboxamide (CHEBI:104887) has functional parent nicotinamide (CHEBI:17154) |
| 2-(4-chloro-2-methylanilino)-3-pyridinecarboxamide (CHEBI:108168) has functional parent nicotinamide (CHEBI:17154) |
| 2-(methylthio)nicotinamide (CHEBI:228655) has functional parent nicotinamide (CHEBI:17154) |
| 2-methylnicotinamide (CHEBI:68440) has functional parent nicotinamide (CHEBI:17154) |
| 2-oxo-N-(2-thiazolyl)-1H-pyridine-3-carboxamide (CHEBI:120549) has functional parent nicotinamide (CHEBI:17154) |
| 5-bromo-N-(4-methyl-2-thiazolyl)-3-pyridinecarboxamide (CHEBI:122191) has functional parent nicotinamide (CHEBI:17154) |
| 5-bromo-N-[(2-pyridinylamino)-sulfanylidenemethyl]-3-pyridinecarboxamide (CHEBI:120534) has functional parent nicotinamide (CHEBI:17154) |
| 5-bromo-N-[(5-nitro-2-thiophenyl)methylideneamino]-3-pyridinecarboxamide (CHEBI:104973) has functional parent nicotinamide (CHEBI:17154) |
| 5-bromo-N-[[(3-methyl-2-pyridinyl)amino]-sulfanylidenemethyl]-3-pyridinecarboxamide (CHEBI:93987) has functional parent nicotinamide (CHEBI:17154) |
| 5-bromo-N-[[(4-methyl-2-pyridinyl)amino]-sulfanylidenemethyl]-3-pyridinecarboxamide (CHEBI:116399) has functional parent nicotinamide (CHEBI:17154) |
| 5-hydroxy-N-[2-[[(5-hydroxy-3-pyridinyl)-oxomethyl]amino]propyl]-3-pyridinecarboxamide (CHEBI:104006) has functional parent nicotinamide (CHEBI:17154) |
| 6-methoxy-4-(trifluoromethyl)nicotinamide (CHEBI:183364) has functional parent nicotinamide (CHEBI:17154) |
| 6-methyl-N-(2-pyridinylmethylideneamino)-3-pyridinecarboxamide (CHEBI:107154) has functional parent nicotinamide (CHEBI:17154) |
| 6-methyl-N-[(2-methyl-3-phenylprop-2-enylidene)amino]-3-pyridinecarboxamide (CHEBI:105981) has functional parent nicotinamide (CHEBI:17154) |
| 6-Methylnicotinamide (CHEBI:88954) has functional parent nicotinamide (CHEBI:17154) |
| acetic acid 2-[[oxo(3-pyridinyl)methyl]amino]ethyl ester (CHEBI:92313) has functional parent nicotinamide (CHEBI:17154) |
| flumetnicam (CHEBI:231554) has functional parent nicotinamide (CHEBI:17154) |
| Himeic acid G (CHEBI:211171) has functional parent nicotinamide (CHEBI:17154) |
| hydroxymethylnicotinamide (CHEBI:134775) has functional parent nicotinamide (CHEBI:17154) |
| Myxochelin N (CHEBI:222142) has functional parent nicotinamide (CHEBI:17154) |
| Myxochelin O (CHEBI:222138) has functional parent nicotinamide (CHEBI:17154) |
| N-(1-adamantyl)-5-hydroxy-3-pyridinecarboxamide (CHEBI:104155) has functional parent nicotinamide (CHEBI:17154) |
| N-(2-fluorophenyl)-2-methyl-6-(trifluoromethyl)nicotinamide (CHEBI:189499) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2-methyl-3-phenylprop-2-enylidene)amino]-3-pyridinecarboxamide (CHEBI:105703) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118385) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118398) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:100861) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118597) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118291) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118425) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:101057) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118445) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:99262) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118736) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:124890) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:124301) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:100693) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118714) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:124865) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:124262) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:102693) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118717) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide (CHEBI:98207) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:124899) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:124859) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118547) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide (CHEBI:98467) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118474) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118386) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118573) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide (CHEBI:97296) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118300) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118418) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118748) has functional parent nicotinamide (CHEBI:17154) |
| N-[(3,3-dimethyl-5-oxocyclohexylidene)amino]-3-pyridinecarboxamide (CHEBI:108969) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95855) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96617) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95777) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95921) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96139) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95864) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96344) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95684) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95995) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95600) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95717) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95552) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95670) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96381) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96468) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95700) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95969) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96539) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95912) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:116657) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5R)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:110094) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95974) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96360) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96511) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96067) has functional parent nicotinamide (CHEBI:17154) |
| N-[[3-methoxy-4-[2-(4-methylanilino)-2-oxoethoxy]phenyl]methylideneamino]-3-pyridinecarboxamide (CHEBI:116480) has functional parent nicotinamide (CHEBI:17154) |
| N-[[5-(4-nitrophenyl)-2-furanyl]methylideneamino]-3-pyridinecarboxamide (CHEBI:116670) has functional parent nicotinamide (CHEBI:17154) |
| N-[1,1,1,3,3,3-hexafluoro-2-(2-pyridinylmethylamino)propan-2-yl]-3-pyridinecarboxamide (CHEBI:94517) has functional parent nicotinamide (CHEBI:17154) |
| N-[2-[2-[2-[[oxo(3-pyridinyl)methyl]amino]ethoxy]ethoxy]ethyl]-3-pyridinecarboxamide (CHEBI:114454) has functional parent nicotinamide (CHEBI:17154) |
| N-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]-3-pyridinecarboxamide (CHEBI:107956) has functional parent nicotinamide (CHEBI:17154) |
| N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]-3-pyridinecarboxamide (CHEBI:105309) has functional parent nicotinamide (CHEBI:17154) |
| N-[6-(1-oxopentylamino)-3-pyridinyl]-3-pyridinecarboxamide (CHEBI:121625) has functional parent nicotinamide (CHEBI:17154) |
| N-methyl-N-[5-(3-pyridinyl)-1,3,4-thiadiazol-2-yl]-3-pyridinecarboxamide (CHEBI:115102) has functional parent nicotinamide (CHEBI:17154) |
| N,N-Dihexylnicotinamide (CHEBI:189375) has functional parent nicotinamide (CHEBI:17154) |
| N'3-(3,4,5-trimethoxybenzylidene)pyridine-3-carbohydrazide (CHEBI:183773) has functional parent nicotinamide (CHEBI:17154) |
| nicorandil (CHEBI:31905) has functional parent nicotinamide (CHEBI:17154) |
| Nicoxamat (CHEBI:173404) has functional parent nicotinamide (CHEBI:17154) |
| nikethamide (CHEBI:134814) has functional parent nicotinamide (CHEBI:17154) |
| Penipyridone A (CHEBI:227809) has functional parent nicotinamide (CHEBI:17154) |
| Penipyridone C (CHEBI:227819) has functional parent nicotinamide (CHEBI:17154) |
| Penipyridone D (CHEBI:227822) has functional parent nicotinamide (CHEBI:17154) |
| Penipyridone F (CHEBI:227832) has functional parent nicotinamide (CHEBI:17154) |
| Pestalamide C (CHEBI:197575) has functional parent nicotinamide (CHEBI:17154) |
| Pestalamide D (CHEBI:215530) has functional parent nicotinamide (CHEBI:17154) |
| Poronitin B (CHEBI:202835) has functional parent nicotinamide (CHEBI:17154) |
| IUPAC Name |
|---|
| pyridine-3-carboxamide |
| INNs | Source |
|---|---|
| nicotinamide | WHO MedNet |
| nicotinamida | WHO MedNet |
| nicotinamidum | WHO MedNet |
| nicotinamide | WHO MedNet |
| Synonyms | Source |
|---|---|
| nicotinic acid amide | ChemIDplus |
| Niacinamide | KEGG COMPOUND |
| Vitamin PP | KEGG COMPOUND |
| 3-pyridinecarboxamide | NIST Chemistry WebBook |
| β-pyridinecarboxamide | ChemIDplus |
| Nikotinamid | ChemIDplus |
| UniProt Name | Source |
|---|---|
| nicotinamide | UniProt |
| Manual Xrefs | Databases |
|---|---|
| C00153 | KEGG COMPOUND |
| NCA | PDBeChem |
| Nicotinamide | Wikipedia |
| DB02701 | DrugBank |
| HMDB0001406 | HMDB |
| D00036 | KEGG DRUG |
| NIACINAMIDE | MetaCyc |
| C00000209 | KNApSAcK |
| US2904552 | Patent |
| US2993051 | Patent |
| LSM-5428 | LINCS |
| 1906 | DrugCentral |
| FDB012485 | FooDB |
| Citations |
|---|